Converting an AEG Cyclotron to H- Acceleration and Extraction

Clinical Trials are under way to evaluate agents labeled with the nuclide 225Ac and its decay product 213Bi, in targeted alpha-immuno-therapy. 225Ac can be produced on a medium-energy cyclotron via the nuclear reaction 226Ra(p,n)225Ac. To demonstrate proof-of-principle, a vintage AEG cyclotron, Model E33, with an internal target, had been employed in a pilot production program at the Technical University of Munich (TUM). To enhance production capability and further support the clinical studies, the TUM facility has recently been refurbished and upgraded, adding a new external beam-line, automated target irradiation and transport systems, new laboratories, hot cells, etc.. An improved high-power rotating target has been built and installed. The AEG cyclotron itself has also been modified and upgraded to accelerate and extract H- ions. We have designed, built, and tested a new axial Penning-type ion source which is optimized for the production of H- ions. The ion source has continued to evolve through experiment and experience. Steady improvements in materials and mechanics have led to enhanced source stability, life-time, and H- production. We have also designed and built a precision H- charge-exchange beam-extraction system which is equipped with a vacuum lock. To fit within the tight mechanical constraint imposed by the narrow magnet gap, the system incorporates a novel chain-drive foil holder and foil-changer mechanism. The reconfigured cyclotron system has now been in operation for more than 1 year. Three long-duration target irradiations have been conducted. The most recent bombardment ran 160 continuous hours at a beam on target of ∼80 microamperes for a total yield of ∼70 milli-curies of 225Ac.